TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Palette Life Sciences AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 (consolidated) |
| Turnover |
97,240
|
61,063
|
358,351 |
| Financial expenses |
17,358
|
39,556
|
40,397 |
| Earnings before taxes |
4,240
|
-341,413
|
-325,438 |
| EBITDA |
21,629
|
-335,661
|
-283,121 |
| Total assets |
706,651
|
880,368
|
374,211 |
| Current assets |
75,964
|
77,757
|
257,496 |
| Current liabilities |
275,256
|
453,213
|
239,402 |
| Equity capital |
431,395
|
427,155
|
-141,901 |
| - share capital |
3,088
|
3,088
|
3,088 |
| Employees (average) |
2
|
2
|
84 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 (consolidated) |
| Solvency |
61.0%
|
48.5%
|
-37.9% |
| Turnover per employee |
48,620
|
30,532
|
4,266 |
| Profit as a percentage of turnover |
4.4%
|
-559.1%
|
-90.8% |
| Return on assets (ROA) |
3.1%
|
-34.3%
|
-76.2% |
| Current ratio |
27.6%
|
17.2%
|
107.6% |
| Return on equity (ROE) |
1.0%
|
-79.9%
|
229.3% |
| Change turnover |
36,177
|
-297,288
|
168,578 |
| Change turnover % | 59% | 89% | |
| Chg. No. of employees |
0
|
-82
|
35 |
| Chg. No. of employees % | 0% | 71% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.